Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CarryGenes Oncology AB
AB
Active
Org 5591961890
Rörstrandsgatan 58, 113 40
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CarryGenes Oncology AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-1M
-1M
-2M
-2M
-3M
2020
-4M
2021
-4M
2022
-5M
2023
-2M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−2 930
−3 696
−3 520
−4 698
−2 199
Depreciation & amort.
−247
−578
−746
−20 313
−0
EBIT
−3 177
−4 274
−4 266
−25 011
−2 199
Net financials
−6
−1 294
663
166
−133
Profit before tax
−3 183
−5 569
−3 603
−24 845
−2 332
Tax
655
1 146
740
−2 541
−0
Net profit
−2 528
−4 423
−2 863
−27 386
−2 332
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
15 206
50 542
51 739
25 428
22 036
Equity
12 216
4 930
48 016
19 613
17 281
Long-term debt
0
0
0
0
0
Short-term debt
2 990
45 612
3 723
5 815
4 755
Total debt
2 990
45 612
3 723
5 815
4 755
Financial ratios
5-year trend
EBITDA margin
-219900000.0%
This company
15.8%
Market median
-1391772252% vs market
2020
2024
Equity ratio
78.4%
This company
38.2%
Market median
+105% vs market
2020
2024
Return on equity
-13.5%
This company
18.4%
Market median
-173% vs market
2020
2024
Net profit margin
-233200000.0%
This company
8.1%
Market median
-2879012446% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on CarryGenes Oncology AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
